To evaluate the impact of comorbid depression in patients with T2DM on work productivity and activity impairment in France, Germany, Italy, Spain and the United Kingdom. Methods: Data were from the 2008 U.S. National Health and Wellness Survey (NHWS), an annual cross-sectional survey of self-reported healthcare behaviors, disease states, and outcomes of adults aged 18+, translated for each country. A cohort of patients with T2DM without comorbid depression was compared to a cohort of T2DM with comorbid depression. Depression was defined as affirmative responses in the past month to: bothered by feeling down, depressed or hopeless; and bothered by having little interest or pleasure in doing things. The Work Productivity and Activity Impairment (WPAI) questionnaire measured productivity; regression models adjusted for gender, age, country, marital status, education and an adjusted Charlson Comorbidity Index score. Results: Among 2668 patients diagnosed with T2DM, 828 (31%) were female and 750 (28%) experienced symptoms of depression. Of 873 employed patients, 275 had symptoms of depression. After controlling for our covariates, employed patients with comorbid depression had significantly worse levels of absenteeism [β=11.15, t=5.66; p<0.001] and impairment while at work (presenteeism) [β=20.96, t=11.72; p<0.001], and had significantly more overall work loss [β=25.58, t=11.59; p<0.001]. For all patients activity impairment was also significantly higher for patients with comorbid depression [β=26.76*, t=21.40; p<0.001]. Germany has a greater amount of presenteeism, and work productivity loss (p<0.05) than the other EU countries compared to the UK in this study; however, France, Germany, Italy and Spain patients experience significantly less activity impairment than UK patients (p<0.05). Conclusions: Patients with T2DM and comorbid depression reported significantly more absenteeism and presenteeism overall. Treating both diseases effectively might lessen burden of disease and related indirect costs; further research is needed to clarify geographical and cultural influence associated with lost productivity. *The value was changed from 22.76 to 26.76 due to a typographical error found during quality checks ABSTRACT -Several factors, including sedentary lifestyle, obesity, and an aging population, contribute to epidemic rates of type 2 diabetes mellitus (T2DM)
1
. Depression frequently occurs with diabetes although it is unrecognized and untreated in approximately two thirds of patients with both conditions 1 .
-Individuals with diabetes and comorbid major depression have higher odds of functional disability compared with individuals with either diabetes or major depression alone 2 . -The prevalence of major depression are high in individuals with chronic medical conditions (hypertension, diabetes, and congestive heart failure), and major depression is associated with significant increases in utilization, lost productivity and functional disability 3 . -Depression and elevated depression symptoms are more prevalent in patients with type 2 diabetes than in those without diabetes and are associated with adverse health outcomes and increased total healthcare utilization
INTRODUCTION
-The purpose of this cross-sectional study was to evaluate and better understand the impact of comorbid depression in patients with T2DM, particularly its impact on work productivity and activity impairment in France, Germany, Italy, Spain and the United Kingdom. A secondary objective was to identify any significant differences in the impact of comorbid depression in patients with T2DM by country of residence. 
OBJECTIVES

Study Measures
Work Productivity and Activity Impairment -Work productivity loss and activity impairment were measured using the general health version of the Work Productivity and Activity Impairment (WPAI) 5 Questionnaire:
• For employed patients (n = 873), three metrics were computed: Absenteeism (percent work time missed due to health) Presenteeism (percent impairment while working due to health) Overall work productivity loss (percent overall work impairment due to health)
• Activity Impairment was computed for all patients (n = 2668).
Statistical Analyses -Bivariate analyses of respondent demographics, comorbidities, and work productivity loss and presenteeism were evaluated by chi-square tests for categorical variables and t-test for continuous variables. -Multivariate multiple regression analyses were conducted, using country (dummy coded with UK as the reference group) as the primary independent variable, controlling for gender, age, marital status, education and an adjusted Charlson Comorbidity Index score 6 . The adaptation was based on the conditions included in NHWS that were most comparable to the conditions in the Charlson Comorbidity Index. The index was calculated by assigning a weight to each condition and then summing the weights for all conditions experienced by each respondent. To further evaluate associations with work productivity and activity impairment. levels of percent work missed in the past week due to health (absenteeism), higher levels of impairment while working due to health (presenteeism) and higher levels of overall work productivity loss than patients without depressive symptoms (p<0.0001 for all). -Amongst all patients with T2DM, patients with comorbid depression had significantly greater levels of activity impairment (56%) compared to the non-depressive patients (27%; p<0.0001).
METHODS
RESULTS (continued) REFERENCES
-Because the data was collected through a web sample, the sample may not be truly representative of the patient population. However, the sample for EU NHWS was collected and weighted as to reflect the general population for each country. -Although clinical information to validate patient responses was not available, this study provides important insights into the outcomes, work productivity loss and resource use of patients with T2DM, despite the noted limitations.
LIMITATIONS
-Employed patients with T2DM and comorbid depression reported significantly more absenteeism, presenteeism, overall work impairment than T2DM patients without depressive symptoms, indicating an unmet need in this population in terms of disease management. -Significantly more activity impairment was also reported for all patients with comorbid depression. -Also, Germany had the greater amount of presenteeism, and work productivity loss than the other EU countries, which may be a function of health system differences or cultural differences. -The findings of this study suggest that more effective and comprehensive disease management is needed in patients with T2DM and comorbid depression, than in patients with T2DM alone, especially since more patients with T2DM and comorbid depression are still working and are younger than those without comorbid depression. 
DISCUSSION AND CONCLUSION
